Senior/Executive Medical Director, Clinical Development (New Indications)

Alumis Inc. is a precision medicines company seeking an Executive Medical Director or Senior Medical Director to lead clinical development strategy and execution for Phase 1 and Phase 2 studies evaluating envudeucitinib and A-005 across new indications.

Requirements

• MD required; board certification or fellowship training in Rheumatology, Dermatology, or a related specialty strongly preferred
• 10+ years of pharmaceutical/biotechnology industry experience in clinical development, with a significant focus on immunology or autoimmune diseases
• Demonstrated experience leading Phase 1 and Phase 2 clinical studies from design through data readout
• Track record of successful regulatory interactions (FDA, EMA) and experience preparing IND/CTA submissions
• Deep understanding of early clinical development, including dose-finding strategies, biomarker integration, and adaptive trial designs
• Strong scientific acumen with the ability to critically evaluate preclinical and clinical data to inform development strategy
• Excellent leadership, communication, and interpersonal skills with the ability to influence cross-functional teams in a matrixed environment
• Strategic mindset with demonstrated ability to balance scientific rigor with business objectives

Benefits

• Generous stock option grants for all employees
• Annual bonus program
• Health insurance premiums paid at 90% for employee, 80% for dependents
• Free access to Genentech Bus & Ferry Share program
• $100 monthly cell phone stipend
• Unlimited PTO for Exempt employees
• Free onsite gym and a kitchen stocked with yummy snacks and drinks!